Blau H - Search Results

1

The Spectrum of Nocardia Lung Disease in Cystic Fibrosis.

Mei-Zahav M, Livnat G, Bentur L, Mussaffi H, Prais D, Stafler P, Bar-On O, Steuer G, Blau H. Mei-Zahav M, et al. Among authors: blau h. Pediatr Infect Dis J. 2015 Aug;34(8):909-11. doi: 10.1097/INF.0000000000000759. Pediatr Infect Dis J. 2015. PMID: 25973994

2

Postnatal management of resolving fetal lung lesions.

Blau H, Barak A, Karmazyn B, Mussaffi H, Ben Ari J, Schoenfeld T, Aviram M, Vinograd Y, Lotem Y, Meizner I. Blau H, et al. Pediatrics. 2002 Jan;109(1):105-8. doi: 10.1542/peds.109.1.105. Pediatrics. 2002. PMID: 11773548

3

Effects of an intensive 4-week summer camp on cystic fibrosis: pulmonary function, exercise tolerance, and nutrition.

Blau H, Mussaffi-Georgy H, Fink G, Kaye C, Szeinberg A, Spitzer SA, Yahav J. Blau H, et al. Chest. 2002 Apr;121(4):1117-22. doi: 10.1378/chest.121.4.1117. Chest. 2002. PMID: 11948041

4

Cystic fibrosis in adults: a changing scene.

Blau H, Livne M, Mussaffi H. Blau H, et al. Isr Med Assoc J. 2003 Jul;5(7):491-5. Isr Med Assoc J. 2003. PMID: 12901245 Free article.

5

Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E. Wilschanski M, et al. Among authors: blau h. N Engl J Med. 2003 Oct 9;349(15):1433-41. doi: 10.1056/NEJMoa022170. N Engl J Med. 2003. PMID: 14534336 Free article. Clinical Trial.

6

The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.

Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, Blumberg RS, Porgador A, Cerundolo V, Mandelboim O. Markel G, et al. Among authors: blau h. Blood. 2004 Mar 1;103(5):1770-8. doi: 10.1182/blood-2003-06-2114. Epub 2003 Nov 6. Blood. 2004. PMID: 14604968 Free article.

7

Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line.

Werber S, Shalit I, Fabian I, Steuer G, Weiss T, Blau H. Werber S, et al. Among authors: blau h. J Antimicrob Chemother. 2005 Mar;55(3):293-300. doi: 10.1093/jac/dkh525. Epub 2005 Jan 19. J Antimicrob Chemother. 2005. PMID: 15659543

8

Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency.

Hanna J, Mussaffi H, Steuer G, Hanna S, Deeb M, Blau H, Arnon TI, Weizman N, Mandelboim O. Hanna J, et al. Among authors: blau h. Blood. 2005 Nov 15;106(10):3465-73. doi: 10.1182/blood-2005-03-0855. Epub 2005 Jul 21. Blood. 2005. PMID: 16037391 Free article.

9

Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease.

Falk B, Nini A, Zigel L, Yahav Y, Aviram M, Rivlin J, Bentur L, Avital A, Dotan R, Blau H. Falk B, et al. Among authors: blau h. Pediatr Pulmonol. 2006 Mar;41(3):234-41. doi: 10.1002/ppul.20342. Pediatr Pulmonol. 2006. PMID: 16429430 Clinical Trial.

10

Cystic fibrosis lung disease: interplay of a microbial microcosm and extremes of inflammation.

Blau H. Blau H. Isr Med Assoc J. 2006 Jan;8(1):58-9. Isr Med Assoc J. 2006. PMID: 16450756 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters